Hilary V. Clegg, Ph.D. - Publications
Affiliations: | 2012 | Genetics & Molecular Biology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Molecular Biology, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Liu Y, Clegg HV, Leslie PL, Di J, Tollini LA, He Y, Kim TH, Jin A, Graves LM, Zheng J, Zhang Y. CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation. Cell Death and Differentiation. 22: 1035-46. PMID 25476776 DOI: 10.1038/cdd.2014.194 | 0.351 | |||
2012 | Clegg HV, Itahana Y, Itahana K, Ramalingam S, Zhang Y. Mdm2 RING mutation enhances p53 transcriptional activity and p53-p300 interaction. Plos One. 7: e38212. PMID 22666487 DOI: 10.1371/Journal.Pone.0038212 | 0.515 | |||
2010 | Clegg HV, Zhang Y. Regulation of the p53 tumor suppressor pathway: the problems and promises of studying Mdm2's E3 ligase function. Critical Reviews in Eukaryotic Gene Expression. 20: 77-86. PMID 20528739 DOI: 10.1615/Critreveukargeneexpr.V20.I1.60 | 0.52 | |||
2008 | Itahana K, Clegg HV, Zhang Y. ARF in the mitochondria: the last frontier? Cell Cycle (Georgetown, Tex.). 7: 3641-6. PMID 19033735 DOI: 10.4161/Cc.7.23.7105 | 0.587 | |||
2008 | Clegg HV, Itahana K, Zhang Y. Unlocking the Mdm2-p53 loop: ubiquitin is the key. Cell Cycle (Georgetown, Tex.). 7: 287-92. PMID 18235222 DOI: 10.4161/Cc.7.3.5358 | 0.5 | |||
2007 | Itahana K, Mao H, Jin A, Itahana Y, Clegg HV, Lindström MS, Bhat KP, Godfrey VL, Evan GI, Zhang Y. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell. 12: 355-66. PMID 17936560 DOI: 10.1016/J.Ccr.2007.09.007 | 0.49 | |||
Show low-probability matches. |